Literature DB >> 18525123

Differential incorporation of tau isoforms in Alzheimer's disease.

Marisol Espinoza1, Rohan de Silva, Dennis W Dickson, Peter Davies.   

Abstract

There are 6 different isoforms of tau expressed in the adult human brain, and little information is available on the cellular distribution of the isoforms. Tau inclusions are found in neurons and occasionally glia in a variety of diseases. Previous studies conducted on brain homogenates suggested that tau isoforms might be differentially incorporated into inclusions. To further elucidate the complex issue of tau isoform composition in Alzheimer's disease (AD) and other neurodegenerative diseases, monoclonal antibodies that differentiate between tau containing residues encoded by exon 10 (4R tau) and tau lacking exon 10 residues (3R tau) were used in single and double labeling immunohistochemistry as well as biochemical analyses of tau isolated from AD and other neurodegenerative diseases. Immunohistochemical analysis of the hippocampus in 34 AD cases performed with these antibodies showed both 3R and 4R tau isoforms in tangles. While biochemical studies showed that both isoforms were present in insoluble tau aggregates in AD hippocampus and cortex, not all tangles appear to be labeled with the 3R and 4R tau specific monoclonal antibodies. Similar studies in progressive supranuclear palsy and Pick's disease confirmed that these diseases were characterized by incorporation of specific isoforms in fibrillar lesions, but lesions in neither disease were exclusively composed of 3R tau or 4R tau isoforms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18525123      PMCID: PMC2882247          DOI: 10.3233/jad-2008-14101

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  42 in total

1.  Structure and novel exons of the human tau gene.

Authors:  A Andreadis; W M Brown; K S Kosik
Journal:  Biochemistry       Date:  1992-11-03       Impact factor: 3.162

Review 2.  Corticonigral degeneration with neuronal achromasia and basal neurofibrillary tangles.

Authors:  W Paulus; M Selim
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

Review 3.  Tau protein pathology in neurodegenerative diseases.

Authors:  M G Spillantini; M Goedert
Journal:  Trends Neurosci       Date:  1998-10       Impact factor: 13.837

4.  Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their tau isoform distribution and phosphorylation.

Authors:  A Delacourte; N Sergeant; A Wattez; D Gauvreau; Y Robitaille
Journal:  Ann Neurol       Date:  1998-02       Impact factor: 10.422

5.  Quantitative neuropathologic analysis of Pick's disease cases: cortical distribution of Pick bodies and coexistence with Alzheimer's disease.

Authors:  P R Hof; C Bouras; D P Perl; J H Morrison
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

6.  Association of an extended haplotype in the tau gene with progressive supranuclear palsy.

Authors:  M Baker; I Litvan; H Houlden; J Adamson; D Dickson; J Perez-Tur; J Hardy; T Lynch; E Bigio; M Hutton
Journal:  Hum Mol Genet       Date:  1999-04       Impact factor: 6.150

7.  A double-labeling immunohistochemical study of tau exon 10 in Alzheimer's disease, progressive supranuclear palsy and Pick's disease.

Authors:  K Ishizawa; H Ksiezak-Reding; P Davies; A Delacourte; P Tiseo; S H Yen; D W Dickson
Journal:  Acta Neuropathol       Date:  2000-09       Impact factor: 17.088

8.  PKA phosphorylations on tau: developmental studies in the mouse.

Authors:  C A Andorfer; P Davies
Journal:  Dev Neurosci       Date:  2000       Impact factor: 2.984

9.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.

Authors:  M Goedert; M G Spillantini; R Jakes; D Rutherford; R A Crowther
Journal:  Neuron       Date:  1989-10       Impact factor: 17.173

10.  Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain.

Authors:  M Goedert; M G Spillantini; M C Potier; J Ulrich; R A Crowther
Journal:  EMBO J       Date:  1989-02       Impact factor: 11.598

View more
  57 in total

Review 1.  Causes versus effects: the increasing complexities of Alzheimer's disease pathogenesis.

Authors:  Siddhartha Mondragón-Rodríguez; Gustavo Basurto-Islas; Hyoung-gon Lee; George Perry; Xiongwei Zhu; Rudy J Castellani; Mark A Smith
Journal:  Expert Rev Neurother       Date:  2010-05       Impact factor: 4.618

2.  Sensitive quantitative assays for tau and phospho-tau in transgenic mouse models.

Authors:  Christopher M Acker; Stefanie K Forest; Ray Zinkowski; Peter Davies; Cristina d'Abramo
Journal:  Neurobiol Aging       Date:  2012-06-21       Impact factor: 4.673

3.  Selective Vulnerability of Brainstem Nuclei in Distinct Tauopathies: A Postmortem Study.

Authors:  Rana A Eser; Alexander J Ehrenberg; Cathrine Petersen; Sara Dunlop; Maria B Mejia; Claudia K Suemoto; Christine M Walsh; Hima Rajana; Jun Oh; Panos Theofilas; William W Seeley; Bruce L Miller; Thomas C Neylan; Helmut Heinsen; Lea T Grinberg
Journal:  J Neuropathol Exp Neurol       Date:  2018-02-01       Impact factor: 3.685

4.  Cigarette smoke induces DNA damage and alters base-excision repair and tau levels in the brain of neonatal mice.

Authors:  Sebastiano La Maestra; Glen E Kisby; Rosanna T Micale; Jessica Johnson; Yoke W Kow; Gaobin Bao; Clayton Sheppard; Sarah Stanfield; Huong Tran; Randall L Woltjer; Francesco D'Agostini; Vernon E Steele; Silvio De Flora
Journal:  Toxicol Sci       Date:  2011-07-21       Impact factor: 4.849

5.  Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies.

Authors:  David J Irwin; Todd J Cohen; Murray Grossman; Steven E Arnold; Sharon X Xie; Virginia M-Y Lee; John Q Trojanowski
Journal:  Brain       Date:  2012-03       Impact factor: 13.501

6.  Exploring the interplay between fibrillization and amorphous aggregation channels on the energy landscapes of tau repeat isoforms.

Authors:  Xun Chen; Mingchen Chen; Nicholas P Schafer; Peter G Wolynes
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-06       Impact factor: 11.205

7.  Tangle evolution linked to differential 3- and 4-repeat tau isoform deposition: a double immunofluorolabeling study using two monoclonal antibodies.

Authors:  Toshiki Uchihara; Makoto Hara; Ayako Nakamura; Katsuiku Hirokawa
Journal:  Histochem Cell Biol       Date:  2011-11-25       Impact factor: 4.304

8.  Cyclic AMP-dependent protein kinase regulates the alternative splicing of tau exon 10: a mechanism involved in tau pathology of Alzheimer disease.

Authors:  Jianhua Shi; Wei Qian; Xiaomin Yin; Khalid Iqbal; Inge Grundke-Iqbal; Xiaosong Gu; Fei Ding; Cheng-Xin Gong; Fei Liu
Journal:  J Biol Chem       Date:  2011-03-02       Impact factor: 5.157

9.  Truncation and Activation of Dual Specificity Tyrosine Phosphorylation-regulated Kinase 1A by Calpain I: A MOLECULAR MECHANISM LINKED TO TAU PATHOLOGY IN ALZHEIMER DISEASE.

Authors:  Nana Jin; Xiaomin Yin; Jianlan Gu; Xinhua Zhang; Jianhua Shi; Wei Qian; Yuhua Ji; Maohong Cao; Xiaosong Gu; Fei Ding; Khalid Iqbal; Cheng-Xin Gong; Fei Liu
Journal:  J Biol Chem       Date:  2015-04-27       Impact factor: 5.157

10.  Neuropathologically defined subtypes of Alzheimer's disease differ significantly from neurofibrillary tangle-predominant dementia.

Authors:  Nicholas J Janocko; Kevin A Brodersen; Alexandra I Soto-Ortolaza; Owen A Ross; Amanda M Liesinger; Ranjan Duara; Neill R Graff-Radford; Dennis W Dickson; Melissa E Murray
Journal:  Acta Neuropathol       Date:  2012-09-12       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.